Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Home sleep apnea testing devices industry 3600 synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Test type trends
2.1.3 Regional trends
Chapter 3 Home Sleep Apnea Testing Devices Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing prevalence of sleep apnea and related co-morbidities
3.3.1.2 Increasing awareness regarding home sleep apnea tests
3.3.1.3 Increasing aging population
3.3.1.4 Product innovation strategy adopted by key industry players
3.3.2 Industry pitfalls & challenges
3.3.2.1 Clinical consequences and economic impact of sleep apnea and related sleep disorders
3.3.2.2 Stringent regulations
3.4 Growth potential analysis
3.4.1 By test type
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.7 Reimbursement scenario
3.8 Technological landscape
3.9 Porter’s analysis
3.10 Competitive landscape, 2021
3.10.1 Competitive matrix analysis, 2021
3.11 PESTEL analysis
Chapter 4 Home Sleep Apnea Testing Devices Market, By Test Type
4.1 Key segment trends
4.2 Type 2
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Type 3
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.4 Type 4
4.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Home Sleep Apnea Testing Devices Market, By Region
5.1 Key regional trends
5.2 North America
5.2.1 Market size, by country, 2017 - 2030 (USD Million)
5.2.2 Market size, by test type, 2017 - 2030 (USD Million)
5.2.3 U.S.
5.2.3.1 Market size, by test type, 2017 - 2030 (USD Million)
5.2.4 Canada
5.2.4.1 Market size, by test type, 2017 - 2030 (USD Million)
5.3 Europe
5.3.1 Market size, by country, 2017 - 2030 (USD Million)
5.3.2 Market size, by test type, 2017 - 2030 (USD Million)
5.3.3 Germany
5.3.3.1 Market size, by test type, 2017 - 2030 (USD Million)
5.3.4 UK
5.3.4.1 Market size, by test type, 2017 - 2030 (USD Million)
5.3.5 France
5.3.5.1 Market size, by test type, 2017 - 2030 (USD Million)
5.3.6 Spain
5.3.6.1 Market size, by test type, 2017 - 2030 (USD Million)
5.3.7 Italy
5.3.7.1 Market size, by test type, 2017 - 2030 (USD Million)
5.4 Asia Pacific
5.4.1 Market size, by country, 2017 - 2030 (USD Million)
5.4.2 Market size, by test type, 2017 - 2030 (USD Million)
5.4.3 China
5.4.3.1 Market size, by test type, 2017 - 2030 (USD Million)
5.4.4 Japan
5.4.4.1 Market size, by test type, 2017 - 2030 (USD Million)
5.4.5 India
5.4.5.1 Market size, by test type, 2017 - 2030 (USD Million)
5.4.6 Australia
5.4.6.1 Market size, by test type, 2017 - 2030 (USD Million)
5.4.7 South Korea
5.4.7.1 Market size, by test type, 2017 - 2030 (USD Million)
5.5 Latin America
5.5.1 Market size, by country, 2017 - 2030 (USD Million)
5.5.2 Market size, by test type, 2017 - 2030 (USD Million)
5.5.3 Brazil
5.5.3.1 Market size, by test type, 2017 - 2030 (USD Million)
5.5.4 Mexico
5.5.4.1 Market size, by test type, 2017 - 2030 (USD Million)
5.5.5 Argentina
5.5.5.1 Market size, by test type, 2017 - 2030 (USD Million)
5.6 Middle East and Africa
5.6.1 Market size, by country, 2017 - 2030 (USD Million)
5.6.2 Market size, by test type, 2017 - 2030 (USD Million)
5.6.3 South Africa
5.6.3.1 Market size, by test type, 2017 - 2030 (USD Million)
5.6.4 Saudi Arabia
5.6.4.1 Market size, by test type, 2017 - 2030 (USD Million)
5.6.5 UAE
5.6.5.1 Market size, by test type, 2017 - 2030 (USD Million)
Chapter 6 Company Profiles
6.1 Competitive dashboard, 2021
6.2 Compumedics Limited
6.2.1 Business overview
6.2.2 Financial data
6.2.3 Product landscape
6.2.4 Strategic outlook
6.2.5 SWOT analysis
6.3 Cadwell Laboratories Inc.
6.3.1 Business overview
6.3.2 Financial data
6.3.3 Product landscape
6.3.4 Strategic outlook
6.3.5 SWOT analysis
6.4 CleveMed
6.4.1 Business overview
6.4.2 Financial data
6.4.3 Product landscape
6.4.4 Strategic outlook
6.4.5 SWOT analysis
6.5 Contec Medical Systems
6.5.1 Business overview
6.5.2 Financial data
6.5.3 Product landscape
6.5.4 Strategic outlook
6.5.5 SWOT analysis
6.6 Itamar Medical Inc.
6.6.1 Business overview
6.6.2 Financial data
6.6.3 Product landscape
6.6.4 Strategic outlook
6.6.5 SWOT analysis
6.7 Koninklijke Philips N.V.
6.7.1 Business overview
6.7.2 Financial data
6.7.3 Product landscape
6.7.4 Strategic outlook
6.7.5 SWOT analysis
6.8 Natus Medical Inc.
6.8.1 Business overview
6.8.2 Financial data
6.8.3 Product landscape
6.8.4 Strategic outlook
6.8.5 SWOT analysis
6.9 Neurosoft
6.9.1 Business overview
6.9.2 Financial data
6.9.3 Product landscape
6.9.4 Strategic outlook
6.9.5 SWOT analysis
6.10 NeuroVirtual/SleepVirtual
6.10.1 Business overview
6.10.2 Financial data
6.10.3 Product landscape
6.10.4 Strategic outlook
6.10.5 SWOT analysis
6.11 Nihon Kohden Corporation
6.11.1 Business overview
6.11.2 Financial data
6.11.3 Product landscape
6.11.4 Strategic outlook
6.11.5 SWOT analysis
6.12 Nox Medical
6.12.1 Business overview
6.12.2 Financial data
6.12.3 Product landscape
6.12.4 Strategic outlook
6.12.5 SWOT analysis
6.13 Resmed
6.13.1 Business overview
6.13.2 Financial data
6.13.3 Product landscape
6.13.4 Strategic outlook
6.13.5 SWOT analysis
6.14 SleepMed
6.14.1 Business overview
6.14.2 Financial data
6.14.3 Product landscape
6.14.4 Strategic outlook
6.14.5 SWOT analysis
6.15 SOMNOmedics GmbH
6.15.1 Business overview
6.15.2 Financial data
6.15.3 Product landscape
6.15.4 Strategic outlook
6.15.5 SWOT analysis
